Ayala Pharmaceuticals, Inc. (19) | License Agreements (3)

Recent Contracts

License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company, as amended (Filed With SEC on May 4, 2020)
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on March 6, 2020)
Evaluation, Option and License Agreement, dated December 19, 2018, between the Registrant and Novartis International Pharmaceutical Limited (Filed With SEC on March 6, 2020)